MVA-EBO Z

BIOLOGICAL2 trials

Sponsors

University of Oxford

Conditions

Ebola Virus Disease

Phase 1

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

TerminatedNCT02451891

University of OxfordEbola Virus Disease

Start: 2015-05-06End: 2017-08-22Updated: 2025-12-18

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

CompletedNCT02485912

University of OxfordEbola Virus Disease

Start: 2015-07-31End: 2016-01-31Updated: 2019-02-06

Related Papers

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal

The Journal of Infectious Diseases2018-11-0482 citations